Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Synchron Stentrode: Brain Computer Interface for Paralysis

The first endovascular neural interface, the Stentrode™ is a minimally invasive implantable brain device that can interpret signals from the brain for patients with paralysis. Implanted via the jugular vein, the #Stentrode is placed inside the #brain in the command-control center, known as the motor cortex, but without the need for open brain surgery. The signals are captured and sent to a wireless unit implanted in the chest, which sends them to an external receiver. We are building a software suite that enables the patient to learn how to control a computer operating system and set of applications that interact with assistive technologies. This #technology has the potential to enable patients with paralysis to take back digital control of their world, without having to move a muscle.

Synchron is currently preparing for pilot clinical trials of the Stentrode™ to evaluate the safety and efficacy of this breakthrough technology.

Find out more at:
synchronmed.com.
https://twitter.com/synchron_ss

MAGNIFY: Duke researcher tracks deadly shapeshifting cancer tumor

Duke University Science and Technology scholar Trudy Oliver, Ph.D, has made progress with small cell lung cancer by systematically profiling it. For the past 30 years, all patients with the disease have been treated the same, with chemotherapy. In the last handful of years, Oliver and other researchers have shown that they can divide the disease into at least four different subtypes, each of which responds differently to treatment.

New study shows circulating anti-insulin CD4 T cells reflect progression of anti-islet immunity

Type 1 diabetes (T1D) is an autoimmune disease linked to helper T-cell recognition in non-obese diabetic (NOD) mice and humans. Moreover, T1D affects the endocrine pancreas, thus causing patients to be dependent on insulin replacement therapy for the rest of their lives. Monitoring disease progression through peripheral blood sampling could provide insights into the immune-mediated mechanisms of T1D.

In a recent study published in Science Translational Medicine, researchers profile antigen-specific helper clusters of differentiation 4-positive (CD4+) T-lymphocytes to determine anti-islet autoimmunity among mice and humans.

Intel Updates x86 Hybrid CPU Cluster Scheduling For The Linux Kernel

The latest iteration of Intel’s cluster scheduling support for x86 hybrid P/E-core CPUs were posted on Friday in seeking to enhance the performance of some workloads under Linux when running on recent Intel Core processors.

Earlier this year Intel posted a new round of Linux cluster scheduling patches after their original implementation I found to be causing regressions and hurting performance at the time with Alder Lake when their original cluster scheduling work was being tackled in 2021. With the 2023 incarnation things appear to be in much better shape.

In June were the v2 patches and on Friday succeeded by a third version. This newest version simplifies how the sibling imbalance is computed and removes the asym packing bias, rounding is added to the sibling imbalance, and some basic changes.

How B-cells and androgens contribute to the development of PCOS

Research on mu heavy chain knockout mice (MuMt-; Bnull), which are mice that are genetically incapable of producing mature B-cells, has suggested that B-cells amplify the metabolic effects of diseases, especially diabetes and insulin resistance. Since type 2 diabetes (T2D) and hyperthyroidism, both of which are autoimmune conditions, are strongly correlated with PCOS, scientists have attempted to investigate an autoimmune trigger for PCOS, which has remained unsuccessful.

Study findings

In the present study, researchers evaluate previously hypothesized factors associated with cyst formation and inflammation, which include B-cell frequency, hyperandrogenemia, and autoantibodies.